| Period Ending | 31-Mar-2010 | 31-Mar-2009 | 31-Mar-2008 | 31-Mar-2007 |
|---|
|
Total Revenue
|
50,913,000
|
51,271,000
|
41,509,000
|
38,761,000
| | Cost of Revenue | 41,002,000 | 42,239,000 | 32,866,000 | 32,575,000 | | |
Gross Profit
|
9,911,000
|
9,032,000
|
8,644,000
|
6,185,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 48,491,000 | 49,469,000 | 39,768,000 | 36,040,000 | | | |
Operating Income or Loss
|
2,423,000
|
1,802,000
|
1,741,000
|
2,721,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 2,423,000 | 1,802,000 | 1,741,000 | 2,721,000 |
|
Interest Expense | (90,000) | (381,000) | (137,000) | (122,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 884,000 | 582,000 | 472,000 | 876,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,715,000 | 975,000 | 1,087,000 | 1,761,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,715,000
|
975,000
|
1,087,000
|
1,761,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.31%